Sinopharm Group Co. Ltd. (SHTDF)
OTC
Closed
Oct 6, 2026
Day's Range
1.8652 wk Range
1.72Overview - SHTDF - Sinopharm Group Co. Ltd.
Key Statistics
Valuation
Enterprise Value
16.07B
P/E (Trailing)
‪6.11‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪0.51‬
EV / EBITDA
‪5.73‬
Profitability
Profit Margin
‪1.24%‬
Operating Margin
‪2.99%‬
Return on Assets
‪2.55%‬
Return on Equity
‪8.04%‬
Ownership
Shares Outstanding
3.12B
Float
1.27B
Held by Insiders
‪0.00%‬
Held by Institutions
‪74.86%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪2.08‬
200-Day Avg
‪2.36‬
Dividends
Payout Ratio
‪30.16%‬
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SHTDF - Sinopharm Group Co. Ltd.
Peers - SHTDF - Sinopharm Group Co. Ltd.
Peer Comparison
Compared with companies in Medical Distribution listed on OTC.
Profile Summary - SHTDF - Sinopharm Group Co. Ltd.
About
Sinopharm Group Co. Ltd. is a prominent pharmaceutical company engaged in the production and distribution of a wide range of medical products and services globally. It primarily focuses on pharmaceuticals and healthcare-related services, including the manufacturing of medicines, developing biologics, and providing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
